Amryt Pharma

26th September 2019

AIM-listed Amryt Pharma (LON: AMYT) has announced a major transactions which will significantly boost their presence in the market. The products treat rare and orphan diseases and makes Amryt one of the global leaders in this space.

We interviewed CEO Dr Joe Wiley, who discusses the deal in the video below.

Amryt Pharma, Video for investors

Amryt are listed on Londons AIM Stock exchange with the ticker LON: AMYT

Amryt Investor Videos

Amryt Investor Videos on Five Minute Pitch TV

Click here to view Amryt Investor Relations Videos